
    
      Design: prospective, randomized, double-blind, dose-finding study with retarded
      phosphatidylcholine.

      Population: 10 patients per dose group (6 doses) - 60 patients Remark: this includes to
      historic groups from another study Inclusion criteria: Ulcerative Pancolitis with chronic
      active course and a clinical index (Rachmilewitz) over 7 and more, endoscopic index of at
      least 7 or more. No systemic steroids or immunosuppressants since 4 weeks.

      Exclusion criteria: Pregnancy & fulminant course
    
  